Conversely, low serum levels of IgG anti-Pg peptidyl arginine deiminase (PPAD) allow greater clinical response to anti-TNF agents in RA patients, significantly reducing DAS28 and APCA levels [35,94,95]. The gene discussed is TNF; the disease is rheumatoid arthritis.